Jorge Luiz Gross

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters et al. · The Lancet · 2010 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +13

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

Guntram Schernthaner, Jorge Luiz Gross, Julio Rosenstock et al. · Diabetes Care · 2013 · 479 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

Ralph A. DeFronzo, Miguel Nasser Hissa, Alan J. Garber et al. · Diabetes Care · 2009 · 416 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study

Lawrence Blonde, Johan Jendle, Jorge Luiz Gross et al. · The Lancet · 2015 · 225 citations

Medicine, Endocrinology, Pharmacotherapy +11

The Type 2 Deiodinase A/G (Thr92Ala) Polymorphism Is Associated with Decreased Enzyme Velocity and Increased Insulin Resistance in Patients with Type 2 Diabetes Mellitus

Luís Henrique Santos Canani, Clarissa Capp, José Miguel Dora et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 207 citations · Full text

Medicine, Endocrinology, Molecular Genetics +16